Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01184501
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
880 | CYCLOHEXYL-{4-[5-(3,4-DICHLOROPHENYL)- 2-PIPERIDIN-4-YL-3-PROPYL-3H-IMIDAZOL- 4-YL]-PYRIMIDIN-2-YL}AMINE | A | 1PMQ | 0.77 | |
FR7 | 1-{(1R,2S)-1-[2-(2,3,-DICHLOROPHENYL)ETHYL]- 2-HYDROXYPROPYL}-1H-IMIDAZOLE-4- CARBOXAMIDE | A | 1V79 | 0.74 | |
224 | 1-({2-[2-(4-CHLOROPHENYL)ETHYL]- 1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE | A | 2DY5 | 0.76 | |
L23 | 4-[1-(2,6-dichlorobenzyl)-2-methyl- 1H-imidazol-4-yl]pyrimidin-2-amine | A,C | 2W71 | 0.74 | |
MIM | [CYCLOHEXYLETHYL]-[[[[4-[2-METHYL- 1-IMIDAZOLYL-BUTYL]PHENYL]ACETYL]- SERYL]-LYSINYL]-AMINE | A | 2NMT | 0.74 | |
MIM | [CYCLOHEXYLETHYL]-[[[[4-[2-METHYL- 1-IMIDAZOLYL-BUTYL]PHENYL]ACETYL]- SERYL]-LYSINYL]-AMINE | A,B | 1IYK | 0.74 | |
778 | 4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN- 1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE | B,C,D,F,G,H, I,J,K,L | 1S64 | 0.72 | |
778 | 4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN- 1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE | B | 1S63 | 0.72 | |
IM9 | 2-{4-[4-({4-[2-methyl-1-(1-methylethyl)- 1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin- 1-yl}-2-oxoethanol | A | 2VV9 | 0.7 | |
S11 | 5-(3,5-DICHLOROPHENYL)THIO-4-ISOPROPYL- 1-(PYRIDIN-4-YL-METHYL)-1H-IMIDAZOL- 2-YL-METHYL CARBAMATE | A | 1EP4 | 0.74 | |
P01 | 2-({6-[(3-CHLOROPHENYL)AMINO]-9- ISOPROPYL-9H-PURIN-2-YL}AMINO)- 3-METHYLBUTAN-1-OL | A | 2IZU | 0.71 | |
P01 | 2-({6-[(3-CHLOROPHENYL)AMINO]-9- ISOPROPYL-9H-PURIN-2-YL}AMINO)- 3-METHYLBUTAN-1-OL | A,B | 1YOM | 0.71 | |
P01 | 2-({6-[(3-CHLOROPHENYL)AMINO]-9- ISOPROPYL-9H-PURIN-2-YL}AMINO)- 3-METHYLBUTAN-1-OL | A | 2Z7S | 0.71 | |
1CI | 1-(4-CHLOROPHENYL)-1H-IMIDAZOLE | A,B,C,D,E,F,G | 2Q6N | 0.71 | |
PFZ | 1-(N-IMIDAZOLYL)-2-HYDROXY-2-(2,3- DICHLOROPHENYL)OCTANE | A | 1PHA | 0.73 | |
PFZ | 1-(N-IMIDAZOLYL)-2-HYDROXY-2-(2,3- DICHLOROPHENYL)OCTANE | A | 1PHB | 0.73 | |
984 | CYCLOPROPYL-{4-[5-(3,4-DICHLOROPHENYL)- 2-[(1-METHYL)-PIPERIDIN]-4-YL-3- PROPYL-3H-IMIDAZOL-4-YL]-PYRIMIDIN- 2-YL}AMINE | A | 1PMN | 0.78 | |
KSF | N-(2-chlorophenyl)-5-phenylimidazo[1,5- a]pyrazin-8-amine | A | 2ZM1 | 0.73 | |
1BN | 1-BENZYL-1H-IMIDAZOLE | A,B | 2AFX | 0.73 | |
ECN | 1-[(2S)-2-[(4-CHLOROBENZYL)OXY]- 2-(2,4-DICHLOROPHENYL)ETHYL]-1H- IMIDAZOLE | A,B | 2UVN | 0.74 | |
TMI | 1-[PHENYL-(4-PHENYLPHENYL)-METHYL]IMIDAZOLE | A | 2BDM | 0.71 | |
XX5 | (S,S)-2-{1-CARBOXY-2-[3-(3,5-DICHLORO- BENZYL)-3H-IMIDAZOL-4-YL]-ETHYLAMINO}- 4-METHYL-PENTANOIC ACID | A | 1R4L | 0.75 | |
OLP | 2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)- 9-ISOPROPYLPURINE | A,B,C,D | 3BPR | 0.73 | |
OLP | 2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)- 9-ISOPROPYLPURINE | A | 2CMW | 0.73 | |
KSM | N-(2-chloro-6-methylphenyl)-8-[(3S)- 3-methylpiperazin-1-yl]imidazo[1,5- a]quinoxalin-4-amine | A | 2ZM4 | 0.71 | |
AP9 | (2S)-2-({6-[(3-AMINO-5-CHLOROPHENYL)AMINO]- 9-ISOPROPYL-9H-PURIN-2-YL}AMINO)- 3-METHYLBUTAN-1-OL | B | 2F2C | 0.7 | |
PB2 | 1-(biphenyl-4-ylmethyl)-1H-imidazole | A,B,C,D | 3G93 | 0.71 | |
PB2 | 1-(biphenyl-4-ylmethyl)-1H-imidazole | A,B,C,D | 3G5N | 0.71 | |
CPZ | 4-(4-CHLOROPHENYL)IMIDAZOLE | A | 1SUO | 0.73 | |
JAN | 6-[(S)-AMINO(4-CHLOROPHENYL)(1- METHYL-1H-IMIDAZOL-5-YL)METHYL]- 4-(3-CHLOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE | B | 1X81 | 0.73 | |
JAN | 6-[(S)-AMINO(4-CHLOROPHENYL)(1- METHYL-1H-IMIDAZOL-5-YL)METHYL]- 4-(3-CHLOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE | B | 1SA4 | 0.73 | |
3BK | (2R,3R,4S,5R)-2-[6-amino-8-[(3,4- dichlorophenyl)methylamino]purin- 9-yl]-5-(hydroxymethyl)oxolane- 3,4-diol | A | 3FZK | 0.71 |